Company Profile
ALXN Stock Price, News & Analysis
- Ticker:
- ALXN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for ALXN.
Company overview
Business overview
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca. Its business centered on high-value specialty medicines for severe, uncommon conditions.
Geographic Base and Sector Classification
Alexion was headquartered in the United States and listed on NASDAQ before its acquisition. It occupied a rare-disease biopharma position with global commercial reach.
Business Model Characteristics
The company relied on specialty drug commercialization, rare-disease access, and the durability of high-value orphan therapies. Investors historically watched launch performance, label breadth, and the sustainability of its rare-disease franchise.
Position Within the Biotechnology Landscape
Alexion was a premium rare-disease biotech name with a strong commercial identity. It stood out because of its orphan-drug focus and the way a narrow portfolio could still create a large market value.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does ALXN do?
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca. Its business centered on high-value specialty medicines for severe, uncommon conditions.
On which exchange is ALXN stock listed?
ALXN (ALXN) is associated with NASDAQ, United States, Biopharma.
What is Alexion?
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca.
Which conditions is ALXN targeting with Alexion?
ALXN is associated with rare disease based on its company overview and current catalyst commentary.
What is Pharmaceuticals?
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca.
What is AstraZeneca?
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca.